FINWIRES · TerminalLIVE
FINWIRES

$NOVT

2 stories mentioning NOVT

Every FINWIRES story that references NOVT, newest first.

Sectors

Sector Update: Healthcare Stocks Rise Pre-Bell Tuesday

Healthcare stocks were rising pre-bell Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.3% higher and the iShares Biotechnology ETF (IBB) advancing by 1%.TG Therapeutics (TGTX) shares were up more than 3% after the company said it has started a phase 2 trial evaluating BRIUMVI as a maintenance therapy following induction with efgartigimod in adult patients with myasthenia gravis, a chronic autoimmune neuromuscular disease.Teleflex (TFX) stock was up more than 1% after the company said four-year follow-up data from its BIOMAG-I study continued to show a favorable long-term safety profile for its Freesolve resorbable magnesium scaffold.Novanta (NOVT) shares were down more than 7% after the company signed a securities purchase agreement for the private placement of about 2.1 million common shares at $140 per share to institutional and other accredited investors, for total proceeds of approximately $300 million. Novanta also said it has agreed to acquire Riverpoint Medical from Arlington Capital Partners for a $1.2 billion upfront cash consideration and potential $250 million milestone payment in Q1.

$IBB$NOVT$TFX$TGTX$XLV
Insider Trading

Novanta Insider Sold Shares Worth $845,325, According to a Recent SEC Filing

Matthijs Glastra, Director, Chief Executive Officer, on April 17, 2026, sold 6,500 shares in Novanta (NOVT) for $845,325. Following the Form 4 filing with the SEC, Glastra has control over a total of 111,143 common shares of the company, with 56,761 shares held directly and 54,382 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1076930/000107693026000076/xslF345X05/form4.xml

$NOVT